Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
Novartis
Novartis
Genmab
Pfizer
Pheon Therapeutics
Ocellaris Pharma, Inc.
Seagen Inc.
Lipomedix Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.
Blueprint Medicines Corporation
Tesaro, Inc.
Sotio Biotech Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Alaunos Therapeutics
Incyte Corporation
Incyte Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Sutro Biopharma, Inc.
Pfizer
Mural Oncology, Inc
Novartis
Incyte Corporation
Alaunos Therapeutics
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Numab Therapeutics AG
Pfizer
NextCure, Inc.
Elevation Oncology
Valerio Therapeutics
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Novartis
Astellas Pharma Inc
Five Prime Therapeutics, Inc.
Pfizer
AbbVie
NantCell, Inc.
Tango Therapeutics, Inc.
Elucida Oncology
NantCell, Inc.
ModernaTX, Inc.
Pfizer
NextCure, Inc.
Hoffmann-La Roche